Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 460-490-0 | CAS number: 477218-42-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12-06-2008 to 13-06-2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- MatTek Corporation EpiOcular™ Eye Irritation Test (OCL-200-EIT)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- inspected: September 2006 ; signature: January 2007
Test material
- Reference substance name:
- -
- EC Number:
- 460-490-0
- EC Name:
- -
- Cas Number:
- 477218-42-1
- Molecular formula:
- C18H32O3
- IUPAC Name:
- 2-[(1S)-1-[(1R)-3,3-dimethylcyclohexyl]ethoxy]-2-methylpropyl cyclopropanecarboxylate; 2-[(1S)-1-[(1S)-3,3-dimethylcyclohexyl]ethoxy]-2-methylpropyl cyclopropanecarboxylate
- Test material form:
- liquid
- Details on test material:
- Physical state: Liquid
- Storage condition of test material: In the refrigerator at + 2 to + 8 °C, protected from light
Constituent 1
Test animals / tissue source
- Species:
- other: human-derived epidermal keratinocyte tissues
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- - Justification of the test method and considerations regarding applicability: The test method is indicated as a validated test method recommended by OECD and/or recognised internationally for the sequential testing strategy for the assessment of ocular irritation.
- Description of the cell system used, incl. certificate of authenticity and the mycoplasma status of the cell live: EpiOcular™ (OCL-200-EIT MatTek Corporation, Lot: 10231 Kit F).
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 50 µL of the test item
- Concentration (if solution): undiluted
VEHICLE
- Amount(s) applied (volume or weight with unit): Not applicable.
- Concentration (if solution): Not applicable.
- Lot/batch no. (if required): Not applicable.
- Purity: Not applicable. - Duration of treatment / exposure:
- Negative control: 60 minutes at 37 ± 1°C
Positive control: 15 and 45 minutes at 37 ± 1°C
Test item: 3, 30 and 60 minutes at 37 ± 1°C - Duration of post- treatment incubation (in vitro):
- 10 to 20 min.
- Number of animals or in vitro replicates:
- Two tissues were used for each treatment group (test item, negative control and positive control).
- Details on study design:
- - Details of the test procedure used: See below.
- RhCE tissue construct used, including batch number: EpiOcular™ (OCL-200-EIT MatTek Corporation, Lot: 10231 Kit F).
- Doses of test chemical and control substances used: 100 µL test item / 100 µL deionised water (negative control) / 100 µL 0.3% Triton X-100 (positive control)
- Duration and temperature of exposure, post-exposure immersion and post-exposure incubation periods (where applicable): After the incubation, the tissues were pre-wetted with 300 µL of assay medium. The tissues were incubated at standard culture conditions (37 ± 1.5 °C, 5 ± 0.5% CO2) until use. After the pre-treatment, the test and control items were tested by applying 100 µL topically on the EpiOcular tissues. The tissues were incubated at standard culture conditions for 60 minutes (negative control), 15 and 45 minutes (positive control) and 3, 30 and 60 minutes (test item). At the end of the treatment time, the test item was removed by extensively rinsing the tissues with PBS (brought to room temperature). After rinsing, the tissues were immediately transferred to and immersed in 5 mL of previously warmed Assay Medium (room temperature) in pre-labelled 6-well plates for a 10-20 minute immersion incubation (post-soak) at room temperature. This incubation in Assay Medium was intended to remove any test item absorbed into the tissue. At the end of the post-soak immersion, each insert was removed from the Assay Medium, the medium was aspirated off the tissue, and the wells were triply rinsed with PBS. The inserts were immersed into extractant solution (2 mL isopropanol) for formazan salt extraction, sealed, and incubated for 18 hours without agitation at room temperature. After the extraction period, the inserts were pierced with an injection needle to allow the extract to run into the well from which the insert was taken. Afterwards the insert was discarded. The well plates were placed on a shaker for 15 minutes until the solution was homogeneous in colour. 3 x 200 µL aliquots of the formazan blue solution were transferred to a well plate and OD was read in a microplate reader at 570 nm without reference filter. Mean values (n=3) were calculated.
- Justification for the use of a different negative control than ultrapure H2O (if applicable): Not applicable.
- Justification for the use of a different positive control than neat methyl acetate (if applicable): Not specified.
- Description of any modifications to the test procedure: Not specified.
- Indication of controls used for direct MTT-reducers and/or colouring test chemicals (if applicable): The test item did not directly-reduce MTT or was colour inference in pre-checks conducted prior to the exposure.
- Number of tissue replicates used per test chemical and controls (positive control, negative control, NSMTT, NSCliving and NSCkilled, if applicable): Duplicate.
- Wavelength and band pass (if applicable) used for quantifying MTT formazan, and linearity range of measuring device (e.g. spectrophotometer): 570 nm
- Description of the method used to quantify MTT formazan: Versamax® Molecular Devices, 85737 Ismaning, Germany – spectrophotometrically.
- Description of the qualification of the HPLC/UPLC-spectrophotometry system (if applicable): Not applicable.
- Description of evaluation criteria used including the justification for the selection of the cut-off point for the prediction model: Not specified.
- Reference to historical positive and negative control results demonstrating suitable run acceptance criteria: Not specified.
- Complete supporting information for the specific RhCE tissue construct used: Attached to the full study report.
- Reference to historical data of the RhCE tissue construct: Full historic control data is attached to the full study report.
- Demonstration of proficiency in performing the test method before routine use by testing of the proficiency chemicals: The test assay is validated at the test laboratory and certification of technical proficiency from the model supplier is attached to the full study report.
- Positive and negative control means and acceptance ranges based on historical data: See above.
- Acceptable variability between tissue replicates for positive and negative controls: Yes, < 6.2 % for positive control, negative control and test item replicates.
- Acceptable variability between tissue replicates for the test chemical: Yes.
Results and discussion
In vitro
Resultsopen allclose all
- Irritation parameter:
- other: Mean tissue viability (% of negative control)
- Remarks:
- n=2
- Run / experiment:
- mean - test item (60 min)
- Value:
- 114
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- other: Mean tissue viability (% of negative control)
- Remarks:
- n=2
- Run / experiment:
- mean - positive control (45 min)
- Value:
- 22.2
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of irritation
- Other effects / acceptance of results:
- The ET50-value of the positive control was calculated to be 14.6 min. An ET50-value could not be calculated for the test item because viability was not reduced, where:
ET50 = a - ((a - b)(c - 50)) / (c - d)
where:
a = max. measured time in min with the% of negative control > 50%
b = min. measured time in min with the% of negative control < 50%
c = relative absorbance at time a in %
d = relative absorbance at time b in %
The lower the ET 50 value, the higher the eye irritant/cytotoxic potential of the test item. For classification purposes, an ET50-value greater than 60 is a non/minimal irritant; a value of 31-60 denotes a mild irritant; 3-30 denotes a moderate irritant and <3 denotes a severe/extreme irritant.
Based on the inability to calculate an ET50, the test item is not predicted to be an eye irritant.
OTHER EFFECTS:
- Visible damage on test system: None.
DEMONSTRATION OF TECHNICAL PROFICIENCY: The test assay is validated at the test laboratory and certification of technical proficiency from the model supplier is attached to the full study report.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes.
- Acceptance criteria met for positive control: Yes.
- Range of historical values if different from the ones specified in the test guideline: See 'details on study design' for further information.
Any other information on results incl. tables
Table 1.0 : Mean absorption and Mean Tissue Viability in the EPIOCULAR Test
Dose Group | Treatment Interval | Mean Absorbance of 2 Tissues | Rel. Absorbance (% of Negative Control) |
Negative Control | 60 min | 1.7315 | 100.0 |
Positive Control | 15 min | 0.8454 | 48.8 |
45 min | 0.3840 | 22.2 | |
Test Item | 3 min | 1.7749 | 102.5 |
30 min | 2.0066 | 115.9 | |
60 min | 1.9739 | 114.0 |
Acceptability of the Assay
a) The absolute mean OD570 of the two tissues of the negative control should reasonably be > 0.8 and < 2.5.
b) The mean relative tissue viability of the positive control should be < 50% relative to the negative control.
c) The difference between the % tissue viabilities of the two identically treated replicates should be < 20%.
All assay acceptability criteria were met.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of this study, the test item is not considered to be an eye irritant.
- Executive summary:
The study was performed to assess the eye irritancy potential of the test item using the EpiOcular EIT model under OECD TG 492 guideline in accordance with GLP. The test item was found to not directly reduce MTT or colour interfere in pre-test checks. The test item was topically applied for 3, 30 and 60 minutes. After exposure the cornea epithelial construct was thoroughly rinsed to remove the test item and transferred to fresh medium for an immersion incubation. The tissues were transferred to fresh medium and incubated under standard culture conditions, prior to determination of the cytotoxic (irritancy) effect. The relative mean tissue viability obtained after treatment with the test item compared to the negative control tissues was 114% (60 min). The positive control had a mean cell viability of 22.2% after 45 minutes treatment. The absolute mean OD570 (optical density at 570 nm) of the negative control tissues was within the acceptability criteria. The difference between the percentages of viability of two tissues treated identically was less than 20%, indicating that the test system functioned properly. Under the conditions of this study, since the test item relative mean viability was > 60% the test item is not predicted to be eye irritant.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.